PRESS RELEASE

MetaMap Tox - A Novel Technology for Early Safety Enablement in Pharmaceutical Development Will be Validated by Industry Consortium
CHA and Metanomics Health GmbH Announce a Collaborative Technology Evaluation

Needham, Massachusetts (USA) and Berlin (GER), 7 April 2011 : The Drug Safety Executive Council (DSEC), an industry membership run by Cambridge Healthtech Associates (CHA), together with Metanomics Health GmbH, a BASF Group company and leader in offering targeted and non-targeted metabolite profiling to healthcare customers, today announced a new project as part of DSEC's Technology Evaluation Consortium. Read more